Medications

FDA: Akynzeo approved for chemo-related nausea / vomiting

(HealthDay)—The combination drug Akynzeo (netupitant and palonosetron) has been approved by the U.S. Food and Drug Administration to treat nausea and vomiting among people undergoing chemotherapy, the agency said Friday ...

Medications

US approves pricey new pill against hepatitis C

US regulators on Friday approved Harvoni, a daily pill to treat hepatitis C that is simpler to administer than long-standing treatments but that carries a steep price tag.

Diseases, Conditions, Syndromes

Animal study holds promise for treating diabetic ulcers and burns

A combination of two drugs already approved by the U.S. Food and Drug Administration for different applications reduces wound healing time by one-quarter and significantly decreases scar tissue in mice and rats, Johns Hopkins ...

Cardiology

Steroids raise cancer risk in TB-associated HIV 

The addition of steroids to tuberculosis (TB) therapy can offer anti-inflammatory benefit to patients with tuberculous pericarditis, a rare cardiac manifestation of TB.

Oncology & Cancer

New combination drug controls tumor growth and metastasis in mice

Researchers at UC Davis, University of Massachusetts and Harvard Medical School have created a combination drug that controls both tumor growth and metastasis. By combining a COX-2 inhibitor, similar to Celebrex, and an epoxide ...

HIV & AIDS

Novel intravaginal ring shows promise for HIV prevention

A novel intravaginal ring implanted with anti-retroviral drug tablets, or pods, demonstrated sustained and controlled drug release and safety over 28 days, according to a paper published ahead of print in Antimicrobial Agents ...

page 19 from 33